JP2010505896A - アシルアミノイミダゾール類およびアシルアミノチアゾール類 - Google Patents

アシルアミノイミダゾール類およびアシルアミノチアゾール類 Download PDF

Info

Publication number
JP2010505896A
JP2010505896A JP2009531766A JP2009531766A JP2010505896A JP 2010505896 A JP2010505896 A JP 2010505896A JP 2009531766 A JP2009531766 A JP 2009531766A JP 2009531766 A JP2009531766 A JP 2009531766A JP 2010505896 A JP2010505896 A JP 2010505896A
Authority
JP
Japan
Prior art keywords
substituents
alkyl
bonded
group
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009531766A
Other languages
English (en)
Japanese (ja)
Inventor
マルクス・バウザー
アーニャ・ブーフミューラー
ジョルジュ・ヴォン・ドゥジャンフェル
エルケ・ディットリッヒ−ヴェンゲンロート
クリストフ・ゲルデス
マルク・イェアン・グノート
ディルク・ゴットシュリング
シュテファン・ハイトマイヤー
マルティン・ヘンドリクス
ヨハネス・ケッバーリング
ディーター・ラング
ウルリッヒ・レスター
ウーヴェ・ザートマン
アドリアン・テルステーゲン
アストリート・ブリュンス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Schering Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma AG filed Critical Bayer Schering Pharma AG
Publication of JP2010505896A publication Critical patent/JP2010505896A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
JP2009531766A 2006-10-11 2007-10-10 アシルアミノイミダゾール類およびアシルアミノチアゾール類 Pending JP2010505896A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006048042A DE102006048042A1 (de) 2006-10-11 2006-10-11 Acylaminoimidazole und Acylaminothiazole
PCT/EP2007/008789 WO2008043533A2 (de) 2006-10-11 2007-10-10 Acylaminoimidazole und acylaminothiazole

Publications (1)

Publication Number Publication Date
JP2010505896A true JP2010505896A (ja) 2010-02-25

Family

ID=39184814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009531766A Pending JP2010505896A (ja) 2006-10-11 2007-10-10 アシルアミノイミダゾール類およびアシルアミノチアゾール類

Country Status (5)

Country Link
EP (1) EP2079708A2 (de)
JP (1) JP2010505896A (de)
CA (1) CA2666177A1 (de)
DE (1) DE102006048042A1 (de)
WO (1) WO2008043533A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013118805A1 (ja) * 2012-02-08 2013-08-15 大日本住友製薬株式会社 3位置換プロリン誘導体

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2350002A1 (de) * 2008-10-02 2011-08-03 Abbott Laboratories Neue verbindungen als kalziumkanalblocker
WO2011115813A1 (en) 2010-03-18 2011-09-22 Abbott Laboratories Lactam acetamides as calcium channel blockers
IN2014MU00072A (de) * 2014-01-08 2015-08-21 Wockhardt Ltd
IL277071B1 (en) 2018-03-08 2024-03-01 Incyte Corp Aminopyrizine diol compounds as PI3K–y inhibitors
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842523A1 (fr) * 2002-07-17 2004-01-23 Sanofi Synthelabo Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
RS50595B (sr) * 2004-03-23 2010-05-07 Pfizer Products Incorporated Jedinjenja imidazola za lečenje neurodegenerativnih poremećaja
DE102006001574A1 (de) * 2006-01-12 2007-07-19 Bayer Healthcare Ag Acylaminoimidazole

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013118805A1 (ja) * 2012-02-08 2013-08-15 大日本住友製薬株式会社 3位置換プロリン誘導体

Also Published As

Publication number Publication date
WO2008043533A2 (de) 2008-04-17
DE102006048042A1 (de) 2008-04-17
WO2008043533A3 (de) 2008-07-03
EP2079708A2 (de) 2009-07-22
CA2666177A1 (en) 2008-04-17

Similar Documents

Publication Publication Date Title
JP4598771B2 (ja) 複素環式化合物
JP4390099B2 (ja) 置換された2−オキソ−3−フェニル−5−カルボニルアミノメチル−1,3−オキサゾリンならびにその抗凝固剤および抗血栓剤としての使用
JP2009543818A (ja) 置換インダゾール類
JP2010506864A (ja) 心血管疾患の処置用のアシルアミノピラゾール類
CA2692178A1 (en) Substituted oxazolidinones and use thereof
JP2010505896A (ja) アシルアミノイミダゾール類およびアシルアミノチアゾール類
RU2605600C2 (ru) Амино-замещенные производные 3-гетероароиламинопропионовой кислоты и их применение в качестве фармацевтических средств
AU2012200212A1 (en) Novel pyrrolidine-3,4-dicarboxamide derivatives
KR20160064100A (ko) 치환된 페닐알라닌 유도체
JP5178712B2 (ja) アリール置換ヘテロ環およびそれらの使用
US20160244437A1 (en) Substituted phenylalanine derivatives
US20160237067A1 (en) Substituted phenylalanine derivatives
JP2009507055A (ja) イミノオキサゾリジン誘導体およびその使用
JP2008521844A (ja) 環状イミノカルバメート類およびそれらの使用
WO2008140220A1 (en) Fxa inhibitors with cyclic amidines as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
JP2008522992A (ja) ピラジンジカルボキサミド類およびそれらの使用
WO2007140982A1 (de) Substituierte benzoxazole
JP2009514822A (ja) フェニレン−ビス−オキサゾリジン誘導体およびそれらの使用
JP2009538845A (ja) イソインドリン−1−オン、イソインドリン−3−オンおよびイソインドリン−1,3−ジオン誘導体ならびにそれらの使用
JP2009538850A (ja) イソインドリン−1−オン、イソインドリン−3−オンおよびイソインドリン−1,3−ジオン誘導体およびそれらの使用
WO2007082666A1 (de) Acylaminoimidazole
JP2009538847A (ja) 置換複素環およびそれらの使用